Association between adverse clinical outcome in human disease caused by novel influenza A H7N9 virus and sustained viral shedding and emergence of antiviral resistance

Webster, 1992, Evolution and ecology of influenza A viruses, Microbiol Rev, 56, 152, 10.1128/MMBR.56.1.152-179.1992 Gao, 2013, Human infection with a novel avian-origin influenza A (H7N9) virus, N Engl J Med, 368, 1888, 10.1056/NEJMoa1304459 Chen, 2013, Human infections with the emerging avian influenza A H7N9 virus from wet market poultry: clinical analysis and characterisation of viral genome, Lancet, 10.1016/S0140-6736(13)60903-4 Subbarao, 1993, A single amino acid in the PB2 gene of influenza A virus is a determinant of host range, J Virol, 67, 1761, 10.1128/JVI.67.4.1761-1764.1993 Li, 2013, Preliminary report: epidemiology of the avian influenza A (H7N9) outbreak in China, N Engl J Med, 24, 24 Lee, 2011, Viral clearance and inflammatory response patterns in adults hospitalized for pandemic 2009 influenza A (H1N1) virus pneumonia, Antivir Ther, 16, 237, 10.3851/IMP1722 de Jong, 2006, Fatal outcome of human influenza A (H5N1) is associated with high viral load and hypercytokinemia, Nat Med, 12, 1203, 10.1038/nm1477 Tse, 2011, Clinical and virological factors associated with viremia in pandemic influenza A/H1N1/2009 virus infection, PLoS One, 6, e22534, 10.1371/journal.pone.0022534 de Jong, 2005, Fatal avian influenza A (H5N1) in a child presenting with diarrhea followed by coma, N Engl J Med, 352, 686, 10.1056/NEJMoa044307 Whitley, 2013, Global assessment of resistance to neuraminidase inhibitors, 2008–2011: the Influenza Resistance Information Study (IRIS), Clin Infect Dis, 56, 1197, 10.1093/cid/cis1220 McKimm-Breschkin, 1998, Mutations in a conserved residue in the influenza virus neuraminidase active site decreases sensitivity to Neu5Ac2en-derived inhibitors, J Virol, 72, 2456, 10.1128/JVI.72.3.2456-2462.1998 Kageyama, 2013, Genetic analysis of novel avian A(H7N9) influenza viruses isolated from patients in China, February to April 2013, Euro Surveill, 18, 1, 10.2807/ese.18.15.20453-en Gubareva, 2004, Molecular mechanisms of influenza virus resistance to neuraminidase inhibitors, Virus Res, 103, 199, 10.1016/j.virusres.2004.02.034 Zurcher, 2006, Mutations conferring zanamivir resistance in human influenza virus N2 neuraminidases compromise virus fitness and are not stably maintained in vitro, J Antimicrob Chemother, 58, 723, 10.1093/jac/dkl321 Chan, 2011, Seasonal influenza A virus in feces of hospitalized adults, Emerg Infect Dis, 17, 2038, 10.3201/eid1711.110205